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ABSTRACT 
In South Africa, very little is known regarding the spectrum of clinical illnesses for which 
older patients are admitted to hospital. Within this group who are admitted, even less is 
known of the burden of HIV disease. This study investigated the clinical indications for 
acute medical admission in adults over the age of 50 years at Chris Hani Baragwanath 
Academic Hospital. The study also determined the prevalence of HIV infection of those 
with HIV, their access and adherence to treatment.  
Methods: This was a prospective, observational study of patients over 50 years of age who 
were acutely admitted to the medical wards of Chris Hani Baragwanath Academic Hospital 
(CHBAH) between August 2014 to March 2015. 
Results:  A total of 200 participants 50 years and older were enrolled, 34% HIV-positive, 
37% HIV-negative and 29% whose HIV status was unknown. The HIV-positive group was 
younger (p <0.0001), had poorer access to pension funds (p<0.0001) and higher burdens of 
acute infectious illness when compared to their HIV-negative counterparts (p<0.0068). 
HIV-negative patients had higher rates of acute cardiovascular and haematological 
conditions (p<0.0001) and higher rates of chronic non-communicable disease (p<0.0004), 
predominantly diabetes mellitus (p<0.0095) and hypertension (p<0.0024). 
Conclusion: In older patients hospitalised for acute illness, both infectious and non-
communicable disease play a significant role however, in those with HIV, the infectious 
burden of disease is more prominent while non-communicable chronic disease 
predominated in those without HIV.
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CHAPTER ONE 
INTRODUCTION AND BACKGROUND TO STUDY 
1.1 Introduction 
South Africa (SA) is in the midst of a profound health and demographic transition that is 
characterized by the increasingly recognized phenomenon of population aging with longer 
life expectancies, greater rates of survival of older patients,  the ongoing burden of 
communicable disease (CD) and the increasing burden of non-communicable diseases 
(NCD) (Mayosi, 2009, Joubert and Bradshaw, 2006). This is taking place despite the 
adverse effects of human immunodeficiency virus (HIV) and the acquired immune 
deficiency syndrome (AIDS) on morbidity and mortality. HIV infection, once considered 
an untreatable fatal illness, is now a treatable chronic disease. The advent of antiretroviral 
therapy (ART) and expanded access to treatment has made a significant contribution to 
survival. Consequently, patient compliance on treatment results in increased longevity with 
average life expectancies that are only slightly lower than that of the communities in which 
they are living(Celesia et al., 2013, Mayosi, 2009, Joubert and Bradshaw, 2006). The latest 
World Health Organization (WHO) and Joint United Nations programme on HIV and 
AIDS (UNAIDS) data has shown that there are approximately 5 million people living with 
HIV in SA and of the 3 million who require ART, 2.2 million are currently accessing 
treatment (WHO, 2013).  
As a result, the HIV pandemic now requires a shift in focus that addresses the impact of 
HIV and other clinical disease on older patients, both the effects on those burdened with 
caring for HIV infected family members and those infected themselves. This has generated 
new concerns regarding the roles that older patients play within society in general, the 
challenges and changes resulting from increasing disease burden and HIV infection 
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(Lekalakala, 2011). In resource limited settings such as those experienced in sub-Saharan 
Africa (SSA) and SA, the effects of this health and demographic transition, in specific 
relation to older patients living with HIV, are important transitions to address.  
 
1.2 Population ageing in sub-Saharan Africa (SSA)  
Population ageing is characterised by declining levels of fertility and mortality. These two 
factors are the major contributors to the surge in the numbers of older patients over the age 
of 60 years in low-to-middle income (LMIC) countries (Joubert and Bradshaw, 2006). This 
transition, initially experienced by high income countries (HIC) has since plateaued. In the 
2001 population census for SA, seven percent of citizens were 60 years and older, similar 
to other LMIC and this is projected to increase to ten percent in the next 20 years (Joubert 
and Bradshaw, 2006). 
In SSA, the decline in fertility reflects a reduction in the numbers of infants born to 
women, while improvement in, and increased access to healthcare has resulted in increased 
longevity. In SA total fertility rates have declined from 6.1 live births per woman in the 
1950’s to current national levels of 2.5 live births per woman (Joubert and Bradshaw, 
2006). Although this number is higher than that seen in HIC, it is far lower than 
comparable birth rates from neighbouring SSA countries, for instance, 7.1 and 4.9 live 
births per woman in Angola and Mozambique respectively(Joubert and Bradshaw, 2006). 
Secondly the decline in infant mortality since the 1990’s as a result of progressive and 
increased treatment of infectious diseases has resulted in the increased survival of children 
into adulthood. This coupled with the decline in adult mortalities under the age of 60 prior 
to 1990 has resulted in longer adult life spans and surges in the numbers seen in the elderly 
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population. This reflects the improvement in healthcare access and resources in South 
Africa, including improved immunization programmes and infrastructures (Joubert and 
Bradshaw, 2006).  
These data highlight the need for implementation of health strategies that will mitigate 
future demands placed on society in relation to the elderly. Even though HIV has not 
halted the process of population aging, new complexities pertaining to comorbidities and a 
higher burden of disease have arisen in older patients who are co-infected with HIV.  In 
those patients who are aging without HIV the social impacts of this disease may leave 
them economically vulnerable and burdened with caring for extended family. HIV 
therefore has an impact on all aging individuals regardless of their HIV status. 
 
1.3 Effects of immunosenescence in the elderly 
Immunosenescence is a natural age-related process of decline that takes place in the human 
immune system. This ageing, in the absence of HIV, is associated with a significant 
decrease in immune function that results in a poor response to immunization and an 
increased risk of morbidity and mortality from pathogen exposure in comparison to the 
younger patient (Rickabaugh and Jamieson, 2010). Immunosenescence is characterised by 
a natural decline in production and decreased output of naive CD4 T cells as a result of 
age-related thymic involution, a decline in the function of circulating T cells, reduced 
memory T cell and cytotoxic CD8 cell populations, all of which increase the risk of new 
infections (Nguyen and Holodniy, 2008a, Fagnoni, 2000). 
In HIV infection, thymic function and production of T cells is also thought to be inhibited 
by HIV itself.  Immunosenescence is compounded by the deleterious effects of the virus on 
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the immune system which increases susceptibility to infection, bringing about further 
physiological as well as immunological decline. Older HIV-positive patients are also prone 
to faster disease progression and reduced T cell reconstitution despite successful viral 
suppression with ART (Rickabaugh and Jamieson 2010). The loss of cytotoxic CD8 cells, 
which play an important role in the containment of HIV replication, in combination with 
loss of CD4 cells, may explain the accelerated progression of HIV infection in older adults 
(Nguyen and Holodniy, 2008b) 
 
1.4 Frailty in the elderly  
Aside from immunosenescence, a physiological decline may occur in the elderly that 
results in reduced reserve in all organ systems increasing morbidity and mortality. This 
physiological decline manifests clinically as frailty. This decline in physiological and 
functional reserves subsequently results in a decreased ability to adapt to extrinsic as well 
as intrinsic stressors (Pathai et al, 2013). The frailty syndrome, which is mainly described 
in the geriatric population is characterized by the findings of at least three of the following 
clinical manifestations: exhaustion, slowed walking speed, low levels of activity, 
weakness, and weight loss (Effros et al., 2008). These factors lead to cognitive as well a 
physical decline, ultimately resulting in falls, increased frequencies of hospitalization as 
well as increased mortality (Pathai et al, 2013). The pathophysiological mechanism of 
frailty is not certain, however it is postulated to be as a result of an increase in the number 
of free radicals, mitochondrial dysfunction, and cytokines that may activate inflammatory 
pathways with age (Effros et al., 2008). HIV itself is an inflammatory state that activates 
similar inflammatory pathways and therefore results in accelerated ageing in those who are 
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infected (Effros et al., 2008). There are however, no defined characteristics of HIV-related 
frailty.  
In studies investigating HIV and frailty, HIV-positive patients were more likely to have 
frailty than those without HIV, women were more affected than men and the prevalence of 
premature frailty in HIV was 5 - 20% (Pathai et al., 2013). Factors associated with an 
increased risk of frailty in HIV were lower socioeconomic status, a lower body mass index 
(BMI), a lower CD4 count (from less than 500) however there was no association with 
duration of ART or the CD4 count at diagnosis (Pathai et al., 2013, Rickabaugh and 
Jamieson, 2010). 
In summary, a number of factors influence the severity of HIV infection in older patients 
including normal age-related immunosenescence, (exacerbated by HIV), a greater degree 
of frailty, poor immune reconstitution despite ART and an increase in the prevalence of 
NCD and CD comorbid disease.  
 
1.5 HIV in an ageing population  
HIV infection in the older population is on the increase. UNAIDS estimates that 3.6 
million people aged 50 years and older are living with HIV worldwide and ten percent of 
these live in LMIC with the majority (74%) in SSA (UNAIDS, 2013a).  
In South Africa in 2010 the prevalence of HIV infection in older adults was estimated to be 
9% and this was likely to increase to 17% by the year 2040 (Negin et al., 2012). These 
figures may be an underestimate as most prevalence data are extrapolated from women of 
reproductive age accessing antenatal care at their respective clinics (UNAIDS, 2013b). 
This method for collecting prevalence statistics contributes to a paucity of prevalence data 
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on HIV in older people (Negin and Cumming, 2010). Currently there is no data on 
prevalence rates of HIV in hospitalised patients. 
 
1.6 Clinical characteristics and manifestations of HIV in older patients 
Currently there are two groups of clinical interest within the older HIV-positive 
population. One includes those who from a younger age are diagnosed with HIV, are 
started on ART and survive beyond the age of 50 years. The second includes those with 
newly diagnosed HIV at age 50 years or older, who require HIV-related care at an older 
age.  
 
1.6.1 Clinical characteristics of older HIV-positive patients on long term ART  
Older HIV-positive patients aging on ART treatment have a different clinical presentation 
compared to those newly diagnosed after age of 50 (Cahill and Valadéz, 2013). They 
present with fewer HIV-related CD but have a higher burdens of non HIV related NCD 
(Cahill and Valadéz, 2013).  
It is not yet known whether long term ART incurs significant drug related comorbidities, 
so that HIV itself may no longer be the primary disease but, instead, a host of other 
complex comorbidities have arisen that may be related to the long term inflammatory 
milieu of HIV infection in the presence of ART (Cahill and Valadéz, 2013). These include 
coronary artery disease, dyslipidaemia, some HIV/non-HIV associated cancers, metabolic 
syndrome, diabetes, osteopaenia/osteoporosis, liver and renal disease and dementia (Negin 
et al., 2012).  The Strategies for Management of Antiretroviral Therapy (SMART) trial 
suggested that morbidity and mortality may be influenced by ART through effects on drug-
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related toxicity (including lipoatrophy, renal dysfunction and neuropathies), inflammation, 
interactions with other chronic infections, such as hepatitis B and C, and other chronic 
NCDs associated with older age including osteoporosis and cardiovascular disease (OAR, 
2012). These studies suggest that HIV and/or its treatment affect and influence the process 
of ageing and/or the development of illnesses typically associated with advanced age. 
Other concerns included the increased rates of cancer. In comparison with the general 
population, patients with HIV experienced a significantly higher incidence of cancers, both 
haematological and solid tumours. In particular, on long term ART there appeared to be an 
increase in the development of non-HIV-related cancers with a decline in HIV-associated 
cancers such as Kaposi’s sarcoma and non-Hodgkin’s lymphoma(Chiao et al., 1999).  
 
1.6.2 Clinical characteristics and outcomes of older patients with newly diagnosed 
HIV infection 
In older, newly diagnosed HIV-positive patients, the clinical course is characterised 
predominantly by AIDS-associated illnesses (of which pneumocystis jiroveci pneumonia 
(PJP) and tuberculosis (TB) are the most common), lower CD4 counts and a marked 
decline in immune function when compared with younger individuals with HIV (Metallidis 
et al., 2013, Tadros et al., 2012). Older patients were also twice as likely to be diagnosed 
later in their course of illness with lower CD4 counts (Smith et al., 2010). Overall, this 
group is at increased risk for an accelerated clinical progression to AIDS and premature 
death (Chiao et al., 1999, Nguyen and Holodniy, 2008a). In SA these adverse outcomes 
may be compounded by lack of access to an appropriate income, housing and 
sanitation.(Lekalakala, 2011).  
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1.7 Hospitalisation of the elderly 
Studies in HIC show that rates of hospitalisation in older patients (irrespective of HIV 
status) account for over 40% of their total admissions with cardiovascular disease as the 
leading cause for admission (Russo, 2006). Data from LMIC countries confirm that 
similarly, approximately 45% of admissions comprise patients over the age of 50 years, 
regardless of HIV status (Eze, 2013, Noor et al., 2015). Compared to HIC, where NCD’s 
predominate as the primary cause for admission, studies from both LMIC  and SSA have 
shown the most common causes for acute medical admission across all age groups was 
infectious and the main risk factors included older age, concurrent comorbidities, gender 
and issues of compliance (Eze, 2013, Noor et al., 2015). It is thought that LMIC will see a 
similar transition (as seen in HIC) over several years from acute CD to NCD (Noor et al., 
2015). Indeed a few S.A studies have already demonstrated such a transition (Mayosi, 
2009, Tollman, 2008). 
In a study conducted in Bushbuckridge, the main causes of mortality and morbidity in 
elderly patients were predominantly due to rising rates of CD (namely HIV and TB), but 
NCD’s were notably on the rise at the time, particularly in those older than 65 (Tollman, 
2008). These patients had predominantly vascular disease, including stroke, ischaemic 
heart disease and hypertensive heart disease.  
In older patients with HIV hospital admission rates have been shown to be higher than in 
younger patients, and they are more likely to demise during the course of admission (Smith 
et al., 2010). In a study from United states conducted over a seven year period the most 
common cause for admission was non-tuberculosis related pneumonia and in those aged 65 
years and older, there were high rates of congestive cardiac disease and coronary heart 
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disease (Tadros et al., 2012). In LMIC, HIV infection is one of the main causes for 
hospitalisation in patients older than 55 years (Gavazzi, 2004b). In the few African studies 
that have investigated hospitalisation of older patients with HIV, most admissions were for 
infectious illnesses manifesting as wasting, fever, weight loss and diarrhoea (Gavazzi, 
2004a). Moreover it was shown that tuberculosis (TB), pneumonia, malaria, leishmaniasis 
and diarrhoeal syndromes had an important impact on mortality. Studies in HIC showed 
PJP as the most common opportunistic infection in older patients with HIV and was the 
most common AIDS defining illness, followed by oesophageal candidiasis and 
disseminated Mycobacterium avium complex (Chiao et al., 1999). (Chiao et al., 1999).  
Despite similarities noted in the prevalence of CD in older and younger patients, older 
patients had higher risks of adverse outcomes in terms of morbidity and mortality as a 
result of these CD (Chiao et al., 1999). This increased risk for morbidity is true despite the 
initiation of ART in those 50 years and older (Rickabaugh and Jamieson, 2010). 
Currently it is unclear how older patients’ living with or without HIV present to hospitals 
in South Africa, hence this study was undertaken. 
 
1.8 Aim 
The primary aim of this project was to investigate the acute clinical presentation of patients 
older than 50 years, irrespective of their HIV status, who were admitted to the medical 
admission ward at CHBAH. The secondary aim was to investigate those who were HIV-
positive in order to determine whether there were any differences in this group, compared 
to their HIV-negative counterparts and to investigate HIV-related aspects of patient illness 
and factors that influence outcomes and access to ART. 
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1.9 Objectives 
The objectives of the study were to (all apply to older adults defined as over the age of 50 
years):  
• Describe the sociodemographics of older patients admitted to CHBAH and to 
compare the demographic profiles of HIV-positive patients to those who are HIV-
negative 
• Describe the spectrum of acute clinical illnesses in older hospitalised patients 
admitted to medical wards whether infectious or non-infectious and compare those 
who are HIV-negative to those who are HIV-positive 
• Describe the non-communicable comorbid illnesses in older patients and compare 
those who are HIV-positive to those who are HIV-negative 
• Determine the prevalence of older HIV-positive patients in this study sample  
• Compare the differences in clinical presentation of older patients with a diagnosis 
of HIV prior to admission to those who were newly diagnosed on this admission
11 
 
CHAPTER TWO 
METHODS 
Permission to conduct this study was obtained from the Human Research Ethics 
Committee (Medical), University of the Witwatersrand, Clearance certificate number 
M140446 (appendix A). A letter of permission from the CEO of CHBAH was obtained 
(appendix B) 
 
2.1 Study design and sample 
This study was conducted as a prospective, observational study of male and female patients 
aged 50 years and older admitted to the medical wards of CHBAH from 01/08/2014 -
22/03/2015. 
 
2.1.1 Geographic details 
CHBAH is a South African hospital located in the heart of Soweto and is responsible for 
providing healthcare services to a vast majority of people residing in the south of 
Johannesburg. It is a tertiary government hospital that accepts referrals from nearby areas 
and provinces as well as a few neighbouring countries, such as Swaziland, Lesotho and 
Mozambique. As a result of its location the preponderance of patients are therefore South 
Africans of black ethnic origin.  
 
2.1.2 Sampling method 
Eligible participants were approached on the day of their admission by the principal 
investigator and asked to participate in the study. A patient information leaflet (appendix 
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D) was given to each potential participant and if agreeable, written informed consent was 
obtained. 
The informed consent process covered the details of the study and the nature of 
information required from the participants, both demographic and medical. After obtaining 
written informed consent, a study number was allocated to each participant and a data 
collection sheet (appendix C) was completed. Exclusion criteria were untreated acute or 
chronic psychiatric illness, dementia, confusion, disorientation or delirium. If a confused or 
disorientated patient recovered normal cognitive function during the course of their stay in 
hospital they were asked to participate. Patients in whom there were language barriers 
between themselves and the researcher were excluded. No interpreters were asked to assist 
in the collection of data. 
The following demographic data were collected: age on day of interview;  employment 
status, if unemployed what were alternative sources of income: a pension, social grant, 
assistance from a family member or begging; number of dependants in the household, 
where a dependant was defined as those who relied upon them financially, irrespective of 
age; type of residence where a “house” pertained to all forms of housing including 
reconstruction and development programme (RDP) housing and a “non-fixed dwelling” 
encompassed living on the street, in a homeless shelter, or no secure/permanent place of 
living. 
The following medical data were collected: HIV status including year and month 
diagnosed; if HIV-positive, the latest CD4 count, HIV viral load and duration of ART (if 
on treatment). In relation to the current admission, the presenting symptoms, duration of 
current illness and history of other chronic medical illnesses were ascertained. 
Participants were examined, appropriate bedside and other investigations carried out, a 
diagnosis made by the attending clinician and treatment initiated. Participants were 
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subsequently followed up in the medical wards and results of blood and other 
investigations were checked. If the admission diagnosis was altered, based on results from 
investigations and the consultant’s assessment, this revised diagnosis was used. 
Participants’, who were diagnosed as HIV-positive at the time of admission, were 
counselled by the doctor and a member of the HIV voluntary counselling and testing 
(VCT) service.  
Confidentiality was maintained throughout the entire process of data collection by ensuring 
patient data were collected from participants in a private room or with curtains drawn at 
the bedside. The data collection sheets were securely stored.  
All data collected were entered onto a RedCap database that is accessible through the 
University of the Witwatersrand. Accessed was granted by the administrator, Irma Mare. 
RedCap is a secure, web-based data collection tool with off-site back up. It also allows for 
the de- identification of patient information and preservation of patient anonymity. 
When reviewing the data for different studies pertaining to older patients, it was noted that 
different age cut-offs were utilized in different studies to describing their cohort of ‘older 
patients’, while some used an cut off age of 50 years and older, others utilized 55 or 60 
years of age as their cut off. For the purposes of uniformity, an age of 50 years has been 
utilized in the description of older patients in this study. 
 
2.2 Statistical analysis 
A descriptive analysis of the data was performed to summarise categorical and continuous 
variables. Categorical data were summarised and presented in percentages.  Continuous 
variables were summarised by either the mean and standard deviation or the median and 
interquartile ranges depending on their pattern of distribution. Comparisons of categorical 
and continuous data were carried out by a number of different tests. Where two groups of 
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categorical data were compared, a Chi2 test was used to compare the proportions of patients 
or data between the two groups. Where less than 100 patients were compared per group, or 
where the numbers within each group were very small a Fisher’s exact test was carried out. 
For comparison of both continuous and categorical data, the t-test method was used and 
where more than one group or multiple variables were compared, the analysis of variance 
(ANOVA) test was utilized. A sample size calculation was also carried out in order to 
determine whether the population size was appropriate and to determine if the sample size 
would answer the key research questions of the study.  It was determined that a study 
population of 200 participants was appropriate for this research. 
Data were analysed using the using SAS (Statistical Analysis System) statistical software 
(version 9.4 for Windows). The statistical analysis was carried out by Dr Petra Gaylard 
(DMSA), who was consulted in November of 2015 to assist with the analysis.
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CHAPTER THREE 
RESULTS 
3.1 Recruitment 
A total of 268 patients were recruited and 200/268 (74.6%) were eligible to participate in 
this study. Of those who were ineligible (68/268; 25.4%), exclusion was based on the 
following criteria: 49/68 (72.1%) were confused; 10/68 (14.7%) had suffered a 
cerebrovascular accident; 6/68 (8.8%) were admitted with seizures; 3/68 (4.4%) each of 
whom were acutely psychotic, too distressed to answer questions without tiring and had an 
incorrect date of birth, respectively. Of the total 200 patients included in the study 67 
(34%) were HIV-positive, 74 (37%) were HIV-negative and the remaining 59 (29%) 
patients’ HIV status was unknown. In the initial proposal, all of the University of 
Witwatersrand’s teaching hospital sites were included as the candidate was unsure whether 
the target sample size would be achieved at one hospital only. Subsequently, all 
participants were recruited from CHBAH and additional sites were therefore not required 
for inclusion in the study.   
 
3.1.1 Social and demographic characteristics of older patients admitted to CHBAH 
The social and demographic data of the study sample (n=200) included the following 
variables: age, gender, ethnicity, residence, employment, income and number of 
dependants (table 3.1). A further sub-analysis was performed comparing the social and 
demographic data of the HIV-positive and HIV-negative groups. This analysis showed the 
HIV-positive group was younger (p<0.0001), had higher levels of informal housing 
(p<0.0001), and fewer received financial support in the form of a pension (p<0.0001) 
(table 3.1). 
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TABLE 3.1 Social and demographic data of older participants admitted to CHBAH 
 
Variable Overall HIV Unknown HIV Positive HIV Negative 
Total population 200 (100%) 59 (29.5%) 67 (33.5%) 74 (37.0%) 
Age Median(IQR) (n=199) 1 59 (54-66)  66 (61-75) 54(52-58) 1  60 (56-66) 1  
Gender (n=200):             
Female 109 (54.5%) 37 (62.7%) 36 (53.7%) 36 (48.6%) 
Male 91 (45.5%) 22 (37.2) 31(46.3%) 38 (51.4%) 
Dependants (n=200):             
0 61 (30.5%) 20 (33.8%) 16 (23.9%) 25 (33.8%) 
1-2 82 (41.0%) 16 (27.1%) 34 (50.7%) 32 (43.2%) 
3-4 39 (19.5%) 17 (28.8%) 12 (17.9%) 10 (13.5%) 
5 or more 18 (9.0%) 6 (10.1%) 5 (7.5%) 7 (9.5%) 
Ethnicity (n=200):             
Black 189 (94.5%) 52 (88.1) 67 (100.0%) 70 (94.6%) 
Indian 6 (3.0%) 5 (8.4%) 0 (0.0%) 1 (1.4%) 
Coloured 5 (2.5%) 2 (3.3%) 0 (0.0%) 3 (4.1%) 
Residence (n=200):         
House2 173 (86.5%) 52 (88.1%) 48 (71.6%)2 73 (98.6%)2 
Shack2 22 (11.0%) 4 (6.7%) 17 (25.4%)2 1 (1.4%)2 
Flat 2 (1.0%) 2 (3.3%) 0 (0.0%) 0 (0.0%) 
Non fixed dwelling 3 (1.5%) 1(1.6%) 2 (3.0%) 0 (0.0%) 
Employed n=200  
Yes 32 (16.0%) 5(8.4%) 16 (23.9%) 11 (14.9%) 
No 168 (84.0%) 54 (91.5%) 51 (76.1%) 63 (85.1%) 
Income (n=200) 
Social Grant 27 (13.5%) 
 
6 (10.1%) 12 (17.9%) 9 (12.2%) 
Pension3 85 (42.5%) 
 
39 (66.1%) 8 (11.9%)3 38 (51.4%)3 
Other 61 (30.5%) 13 (22.0%) 31 (46.3%) 17 (23.0%) 
1p<0.0001 HIV-positive participants were significantly younger than HIV-negative participants 
2p<0.0001 HIV-positive participants had significantly less access to formal housing than HIV-negative 
participants 
3p<0.0001HIV-positive participants had significantly less access to a pensions funds  
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3.1.2 The spectrum of acute medical illness for which older patients were admitted at 
CHBAH 
The spectrum of acute medical illness for which older patients were admitted were 
categorised, in decreasing order of frequency as respiratory, cardiac, GIT, genito-urinary, 
haematological, neurological and rheumatologic (table 3.2). A sub-analysis performed to 
compare HIV-positive and HIV-negative patients showed no statistically significant 
difference within each category when comparing the two groups however, there were 
significantly more infectious illnesses in the HIV-positive group (table 3.2). Although not 
statistically significant; the HIV-positive group had higher numbers of patients with 
respiratory and gastro-intestinal illnesses, while patients who were HIV-negative had a 
higher proportion of cardiac disease.  
 
TABLE 3.2 Spectrum of acute medical illness in older patients admitted to CHBAH 
 
1p =0.0068 HIV-positive participants had significantly higher rates of infectious illnesses than HIV-negative 
2These numbers represent the number of participants in each subgroup as well as the denominator by which 
the variable is divisible. 
Variable 
(Clinical Disease) 
Overall 
(x/200)2 
HIV Unknown 
(x/59)2 
HIV Positive 
(x/67)2 
HIV Negative 
(x/74)2 
Respiratory  78/200 (39.0%) 19/59 (32.2%) 33/67(49.3%)  26/74 (35.1% ) 
Cardiac  49/200 (24.5%) 21/59 (35.6%) 9/67 (13.4%)  19/74 (25.7% ) 
Gastro-intestinal  38/200 (19.0%) 5/59 (8.5%) 20/67 (29.9%)  13/74 (17.6% ) 
Genito-urinary  27 /200(13.5%) 12/59 (20.3%) 7/67 (10.4%)  8/74 (10.8% ) 
Neurological  20 /200 (10.0%) 4/59 (6.7%) 8/67 (11.9%)  8/74 (10.8%) 
Haematological  26/200 (13.0%) 4/59 (6.7%) 10/67 (14.9%)  12/74 (16.2% ) 
Rheumatologic  2/200 (1.0%) 0/59 (0.0%) 0/67 (0.0%)  2/74 (2.7% ) 
Other  39/200 (19.5%) 16/59 (27.1%) 7/67 (10.4%) 16/74 (21.6%) 
Infectious illness 94/200 (47%) 21/59 (22.3%) 43/67 (45.7%)1 30/74 (31.9%)1 
Non-infectious 
illness 106/200 (53%) 38/59 (35.8%) 24/67 (22.6%) 44/74 (41.5%) 
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3.1.3 Chronic non-communicable comorbid illnesses in older patients admitted to 
CHBAH 
Table 3.3 represents the chronic clinical co-morbidities for the group overall. These 
included hypertension, diabetes, ischaemic/cardiac disease, dyslipidaemia, chronic kidney 
disease (CKD) and chronic obstructive pulmonary disease (COPD) Overall, hypertension 
and diabetes were the most common. When comparing the HIV-positive and negative 
groups, a significantly higher proportion of HIV-positive participants had very few or no 
comorbidities (p<0.0004). Furthermore, a significantly higher proportion of HIV-negative 
participants had hypertension and diabetes (p<0.0024 and <0.0095 respectively). 
 
Table 3.3 Comparison of chronic non-communicable comorbidities in older patients 
admitted to CHBAH 
 
Co-morbidities 
Overall 
(x/200) 4 
HIV Unknown 
(x/59) 4 
HIV Positive 
(x/67) 4 
HIV Negative 
(x/74) 4 
None1 47/200 (23.5%) 6/59 (10.1%) 29/67 (43.3%)1 12/74 (16.2%)1 
Hypertension2 120/200 (60.0%) 48/59 (81.3%) 25/67 (37.3%)2 47/74 (63.5%)2 
Diabetes3 42/200 (21.0%) 25/59 (42.5 %) 3/67 (4.5%)3 14/74 (18.9%)3 
Dyslipidaemia 2/200 (1.0%) 2/59 (3.9%) 0/67 (0.0%) 0/74 (0.0%) 
Ischaemic/ 
Cardiac disease 17/200 (8.5%0 8/59 (13.6%) 2/67 (3.0%) 7/74 (9.5%) 
CKD 10/200 (5.0%) 1/59 (1.7%) 3/67 (4.5%) 6/74 (8.1%) 
COPD /chronic 
lung disease 24/200 (12.0%0 5/59 (8.5%) 6/67 (9.0%) 13/74 (17.6%) 
Other 62/200 (31.0%) 16/59 (27.1%) 20/67 (29.9%) 26 /74 (35.1%) 
1p =0.0004 A significantly higher proportion of HIV-positive participants had no comorbid NCD than HIV-
negative participants 
2p =0.0024 HIV-negative participants had significantly higher rates of hypertension than HIV-positive 
participants 
3p =0.0095 HIV-negative participants had significantly higher rates of diabetes mellitus than HIV-positive 
participants 
4These numbers represent the number of participants in each subgroup as well as the denominator by which 
the variable is divisible. 
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3.2 Comparison of infectious and non-infectious causes for the acute medical 
presentation to hospital in older patients admitted to CHBAH 
Overall, 94/200 (47.0%) patients presented with an acute infectious illness as the cause of 
their admission. However, when comparing the HIV-positive to the HIV-negative group, 
statistically more HIV-positive patients presented with an infectious aetiology 43/94 
(45.7%) versus 30/94 (31.9%) in the HIV-negative group; (p= 0.0068). The difference in 
the rates of infectious illness according to HIV status, time at diagnosis and duration on 
ART is demonstrated in Table 3.4. 
 
Table 3.4 Comparison of infectious and non-infectious causes of acute illness 
according to HIV status in older patients admitted to CHBAH 
Participants 
Non-infectious 
(x/106) 2 
Infectious 
(x/94) 2 
Total participants 106 (53%) 94 (47%) 
HIV Positive Participants 
with/out infectious illness 24 /106 (22.6%) 43/94 (45.7%)1 
HIV Negative Participants 
with/out infectious illness 44/106 (41.5%) 30/94 (31.9%)1 
HIV Unknown with/out 
infectious illness 38/106 (35.8%) 21/94 (22.3%) 
HIV Positive on admission 
with/out infectious illness  6/106 (25.0%) 14/94 (32.6%) 
HIV Positive Prior to 
admission with/out infectious 
illness 18/106 (75.0%) 29/94 (67.4%) 
On ART: 
Yes 13/106 (54.2%) 14/94 (32.6%) 
Not on A RT 9/106 (37.5%) 27/94 (62.8%) 
1p =0.0068 HIV-positive participants had significantly higher rates of infectious illnesses than HIV-negative 
2These numbers represent the number of participants in each subgroup as well as the denominator by which 
the variable is divisible 
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3.2.1 Aetiology of acute infectious and non-infectious illnesses in older patients 
admitted to CHBAH  
The aetiology of acute infectious and non-infectious illnesses on admission are presented 
in Table 3.5 and include respiratory, cardiac, GIT, genito-urinary, neurological, 
haematological, rheumatologic and other systems of disease. In those with an infectious 
aetiology, a significantly higher proportion had conditions affecting the respiratory and 
gastro-intestinal systems (p=<0.0001 and p=0.013 respectively) when compared to the 
non-infectious group. In those with a non-infectious aetiology, significantly higher 
proportion had cardiac or haematological disease (p=0.0010 and p=<0.0001) respectively.  
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Table 3.5 Differences in acute clinical diagnosis between infectious and non-infectious 
older patients admitted to CHBAH   
Variable Non-Infectious Infectious 
Respiratory1  17 (16.0%)1 61 (64.9%)1 
Cardiac2  36 (34.0%)2 13 (13.8%)2 
GIT3 13 (12.3%)3 25 (26.6%)3 
Genito-urinary  6 (5.7%) 21 (22.3%) 
Neurological  12 (11.3%) 8 (8.5%) 
Haematological4 23 (21.7%)4 3 (3.2%)4 
Rheumatologic 2 (1.9% 0 (0.0%) 
Other  19 (17.9%) 20 (21.3%) 
1p <0.0001 Participants in the infectious group had significantly higher rates of respiratory infectious illnesses 
compared to the non-infectious groups 
2p =0.0010 Participants in the non-infectious group had significantly higher rates of non-infectious cardiac 
illnesses compared to the infectious groups 
3p =0.013 Participants in the infectious group had significantly higher rates of GIT illnesses compared to 
non-infectious participants 
4p <0.0001 Participants in the non-infectious group had significantly higher rates of haematological illnesses 
compared to the infectious participants 
 
3.3 Older HIV-positive patients admitted to CHBAH 
67/200 (%) older patients in this study were HIV-positive. Of these patients, 47/67 (70.1%) 
participants had a known HIV-positive diagnosis at the time of admission and the 
remainder were diagnosed on the admission 20/67 (29.9%). A large proportion of the 
participant’s HIV status remained unknown 59/200 (29%). Of the 47/67 (70.1%) who had 
been diagnosed prior to admission, half of these participants 27/47(57.4%) were on ART. 
For this component of the study, analysis was done for all of the HIV-positive older 
patients and then comparing those who were newly diagnosed on admission to those whose 
HIV-positive status was known on admission. Parameters compared included CD4 count, 
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viral load and the presence of /absence of ART. These findings are represented in Table 
3.6. 
 
3.3.1 Comparison of new and previously diagnosed HIV-positive older patients 
admitted to CHBAH 
There were no significant differences between those with known HIV infection and those 
who were diagnosed on admission when comparing demographics, symptoms, clinical 
presentation and comorbidities. As a result, these findings are not tabulated or represented 
in a graphical format. Median CD4 count, HIVVL and presence/absence of ART were 
compared for the newly diagnosed and known HIV-positive groups; between the infectious 
and non-infectious groups of HIV-positive patients as well as for those patients on /not on 
ART (table 3.6). 
 The CD4 counts were noted to be significantly lower in patients who were undiagnosed at 
admission, compared to those already diagnosed at admission (p=0.018). When comparing 
the group that presented with infectious illnesses compared to those with non- infectious 
illnesses, the CD4 counts once again were significantly lower in the former compared to 
the latter group (p=0.0027).  
The HIVVL was higher in those who were newly diagnosed compared to those already 
diagnosed on admission; this effect was not statistically significant. When comparing those 
patients who were and were not on ART, those who were on ART had significantly lower 
HIVVL (p= 0.018), this effect was expected.  
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TABLE 3.6 Comparison of CD4 counts and HIVVL in newly diagnosed and known older HIV-positive patients admitted at CHBAH 
 
Variable HIV+ Overall 
HIV Positive on 
Admission 
HIV Positive Post 
Admission HIV Positive on ART 
HIV Positive Not on 
ART 
 
Total HIV positive/ Total no. 
patients (67/200) 67/200 (33.5%) 47/67 (70.1%) 20/67 (29.9%) 27/67 (40.3%)6 36/67 (53.7%)6 
4CD4 Count Median(IQR) 
154 
 (70 – 317) 
2051  
(92 – 361) 
871 
 (28 – 281) 
185 
 (88- 329) 
137  
(49-317) 
5HIVVL Median(IQR) 
4.71  
(2.0- 5.35) 
 4.08 
 (1.30–5.18) 
5.05  
(4.75– 5.50) 
2.002 
 (0.5- 3.80)  
5.002  
(4.80- 5.50 
 
1p =0.018 CD4 counts were significantly lower in participants who were newly diagnosed HIV-positive compared to those who were HIV-positive on admission 
2p =0.018 HIVVL were significantly higher in participants on ART compared to those not receiving ART 
3p =0.0027 CD4 counts were significantly lower in participants with infectious illnesses compared with those with non-infectious illnesses 
4CD4 count (cells/mm3), 5 participants had missing CD4 count results 
5 HIV viral load (log copies/ml), 10 participants had missing HIVVL results 
6Missing data: 4 participants had missing data regarding whether they were receiving ART or not 
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CHAPTER FOUR 
DISCUSSION 
4.1 Demographics and socio-economic status in older patients 
Overall, the median age of the study sample was 59 (range 54 - 66) years of age with those 
in the HIV infected group being significantly younger than the HIV-negative group, 
median age of HIV-positive group was 54 years (range of 54 – 58). There is very little data 
from SSA countries, however, studies from LMIC such as Sudan and Nigeria demonstrated 
similar ages for acute admissions in elderly patients at 56 years and older (Eze, 2013, Noor 
et al., 2015). None of these studies however elucidate the average age of their HIV-positive 
versus the HIV-negative participants at admission. A UK based study showed the median 
age at diagnosis of older patients with HIV in their cohort was 55 years (Smith et al., 2010) 
bearing similarities to the median age of the HIV-positive patients in this study.  
Rates of unemployment were high with many relying on social grants, pension funds and 
family assistance to support their day to day living. Unemployment rates were most 
relevant in participants younger than 60 years of age as they continue to make up part of 
the national workforce as opposed to those over the age of 60 who are expected to be 
unemployed or retired. Despite this, HIV-positive participants demonstrated poorer socio-
economic circumstances than their HIV-negative counterparts, with significantly fewer 
patients accessing monetary funds in the form of a social grant or pension fund to support 
their daily living (table 3.1). The lack of pension funding in the HIV-positive group may 
also be the result of ineligibility due to younger age. HIV-positive participants were further 
compromised by their lack of access to formal housing rendering them more economically 
unstable.  
Adult pension funds and social grants are a very necessary monetary tool in many of the 
socioeconomically disadvantaged communities in this country and this study was no 
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exception. Indeed studies in SA have demonstrated that older patients often utilize their 
pension funds as the primary income in the home (Hosegood, 2006). In 2006, a study in 
Kwa-Zulu Natal (KZN) revealed that adult pensions were the only source of income in 
one-third of households with 30 to 40% of the pension being responsible for school 
expenses for dependants, while the rest was utilized for other household needs. Benefits for 
the older patients are that of being cared for in a family unit and the provision of necessary 
assistance in carrying out activities of daily living. Their pension fund is therefore thought 
to confer a protective effect on health, not only on the older patient but on their dependants 
as well (Hosegood, 2006). On the other hand, because of the dependence of other family 
members on their small income the older person is vulnerable in terms of financial security 
and economic stability.  
 
4.2 Differences in hospitalisation of older men and women 
Higher numbers of older women than men were admitted during the course of this study. 
This is a finding different from that seen in other studies where males appeared to have 
higher rates of help seeking behaviour than women (Noor et al., 2015, Tadros et al., 2012, 
Eze, 2013, Odenigbo, 2009). This difference may be explained by the observation that in 
most African countries women constitute the majority of the older population. Potential 
explanations for this in SA have been higher life expectancy observed in women and high 
male mortality due to accidents and homicide (Hosegood, 2006, Joubert and Bradshaw, 
2006) . Although women accounted for higher population numbers, because of lifelong 
gender disadvantages, including poorer socioeconomic status, income instability and 
vulnerability (as a result of being widowed) women are more at risk of higher rates of 
morbidity(Joubert and Bradshaw, 2006). These factors are also thought to be some of the 
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mechanisms increasing women’s vulnerabilities and risks of acquiring HIV/AIDS. Studies 
also revealed that older females were more likely than men to require admission to hospital 
and that despite the initiation of ART, women continued to have worse morbidity. This 
may also be an explanation for the preponderance of female participants found in this study 
(Mugavero et al., 2007, Antoniou, 2012).  
 
4.3 Hospitalisation of older adults and the spectrum of clinical illness, both infectious 
and non-infectious 
The greater burdens of acute medical illness in patients admitted to CHBAH were for 
respiratory, cardiac and gastrointestinal disease, this was independent of HIV status and 
whether the disease was infectious or not. Many elderly patients, particularly those in the 
HIV-negative group presented predominantly with NCD (cardiovascular and 
haematological). Many of the HIV-positive patients presented with high rates of infectious 
disease in comparison to HIV-negative participants. These infectious illnesses involved the 
respiratory and gastro-intestinal tract, with a preponderance of pneumonia, tuberculosis 
and gastro-enteritis specifically. The prevalence rate of HIV in these hospitalised patients 
was high. 
These findings bear similarity to those in HIC countries in that cardiovascular, respiratory 
and GIT ranked amongst the most foremost causes for hospitalisation (Russo, 2006, Tadros 
et al., 2012, Akgun et al., 2013). They also revealed higher rates of respiratory 
communicable disease as a cause of admission in their HIV-positive group of patients 
(Akgun et al., 2013, Tadros et al., 2012). 
The high burden of HIV infection in this study group, the low number of patients on ART, 
and the relatively low numbers of viral suppression in those receiving ART may be the 
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contributory factors to the infectious burden of disease noted. This may be further 
compounded by the poor socioeconomic factors that were observed.  
A third of patients recruited to this study did not know their HIV status and this may be a 
reflection of the delay in the health system in recognizing older patients as an at risk group. 
It may also result in patients being tested late in the clinical course of disease or once all 
other diagnoses have been excluded. Older patients lack of education and understanding as 
well as social stigmata regarding the disease may also be a major contributory factor in 
patients denying or delaying testing. In a UK study conducted over an eight year period in 
which late diagnosis was significantly higher in older adults, several factors including 
missed opportunities in the health care system, patient education and perception of risk 
were most influential in late HIV diagnosis in their cohort of older patients (smith et al). 
 
4.4 Non-communicable comorbid illnesses in older patients  
The HIV-negative group in the study had a significantly higher proportion of chronic non-
communicable co-morbid disease, with hypertension and diabetes mellitus being the most 
common. Fewer HIV-positive patients had NCD, these findings may have been 
confounded by the younger age of admitted HIV-positive patients as most NCD will 
increase with older age.  
One of the earliest ground breaking studies that have been instrumental in demonstrating 
rising rates of non-communicable diseases in SA is the Agincourt study. It demonstrated 
that despite rising rates of HIV and TB, morbidity and mortality from non-communicable 
disease have increased, ranking highest as a cause for illness particularly in those patients 
aged 65 years and older. The predominating disease in these patients were  vascular 
diseases (Tollman, 2008). Many HIC have demonstrated an epidemiological transition with 
28 
 
a reduction in CD and rising rates of NCD within the adult population (Noor et al., 2015). 
In this group of patients these high rates of NCD are most likely a reflection of increased 
burden of NCD at an older age. 
 
4.5 HIV and its’ effects in this cohort of older patients 
HIV prevalence rates in hospitalised patients were 33.5% in the study with 75% having 
had a diagnosis of HIV prior to admission. These numbers may be higher still as 29.5% of 
the study participants were not tested for HIV during the course of their admission. Only 
40.3% of participants previously known to be HIV positive at the time of admission were 
accessing ART yet their median CD4 counts were well below 350ml/cell3which was the 
level previously required to initiate ART. Furthermore CD4 counts were significantly 
lower in those patients who were newly diagnosed compared to those who were already 
known as well as those with infectious illnesses.  
The in hospital prevalence rates of HIV-positive patients in the study were high. National 
HIV prevalence was 7.6% in 2012 with rates of 12.4% in the Gauteng province (Shisana et 
al., 2014). A study conducted in Thessaloniki, Greece, over a 10 year period reported an 
HIV prevalence rate of 18.5% in hospitalised patients, higher than the national prevalence 
of 15.1% at the time (Metallidis et al., 2013). Younger patients in SA also demonstrated an 
in hospital prevalence rates of 60.1 % compared to the national prevalence of 18.8% in 
those 15-49 years of age in a study conducted in Cape Town over a 16 month period 
(Meintjes et al., 2015, Shisana et al., 2014). 
There are no studies from SA with in-hospital data demonstrating prevalence rates of HIV 
in elderly patients. SA prevalence data available from community based studies 
demonstrate rising rates of HIV infection among the elderly. These rates were as high as 
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7.8% in women and 12.9% in men in a community based study in rural KZN (Wallrauch et 
al., 2010). 
The advent of ART and its exponential scale up programme in SA has played a significant 
role in the survival of patients receiving ART into older age.  The larger majority of HIV-
positive patients (75% of the group) who knew of their HIV status prior to admission are 
testament to voluntary testing and counselling taking place within communities. Several 
factors still exist that contribute to poor ART access, despite awareness of HIV status and 
non-compliance as few of the patients requiring ART (40.3%) were receiving it in this 
study. Other studies also demonstrate poor ART access in the SA setting with 34.4% of the 
84.4% of the patients diagnosed prior to admission and requiring ART accessing it 
(Meintjes et al., 2015). This was demonstrated in a younger population of patients in SA, 
however many of the determinants hindering access to ART and compliance are applicable 
to an older population. Although the reasons for lack of ART access were not explored, 
factors that may impact on compliance may include patient refusal, delayed initiation, poor 
follow up or patient ineligibility (Meintjes et al., 2015). 
In this study, older patients with HIV who were not on ART demonstrated very low 
median CD4 counts implying late presentation with advanced clinical disease. A UK study 
conducted over a seven year period revealed late presentation in a significant number of 
older patients with CD4 counts below 200 compared to younger participants (Smith et al., 
2010).  HIV and ageing have a combined deleterious effect on CD4 cells/mm3 counts 
worsening risks of adverse morbidity and mortality. Other studies have already alluded to, 
the slow recovery of the immune system in older patients with HIV who are initiated on 
ART. Patients on ART in the study demonstrated higher median CD4 counts in 
comparison to those who were not initiated, however these remained well below the 
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national CD4 required for ART initiation demonstrating poor immune recovery and 
perhaps rendering them vulnerable to ongoing opportunistic infections.  
Themba Lethu, an ART clinic in Helen Joseph Hospital, conducted a study in which the 
majority of older patients mounted poorer clinical response to ART by 6 and 12 month 
follow up compared to younger patients. (Maskew et al., 2012). Viral suppression in their 
study, however was noted to be better in patients 50 years and older and this was attributed 
to older people having better adherence to therapy in comparison to their younger 
counterparts (Maskew et al., 2012). Studies from HIC also demonstrated adequate 
virological suppression but  slower rates of immunological recovery in older patients 
(Gebo, 2008). Viral suppression was suboptimal in patients on ART in this study, perhaps 
as a result of inadequate compliance on ART and viral resistance. 
Some studies have  alluded to the potential benefits of initiating ART at higher CD4 
counts, including the decrease in syndromes such as HIV associated frailty, decrease in 
opportunistic infections and improvement in health outcomes, which has implications for 
the findings in this study (Smith et al., 2010). 
 
4.6 Limitations of this study 
1. Diagnosis of acute condition: difficulties were encountered in some patients as 
many had ongoing investigations which may have altered the diagnosis at the time 
of presentation to time of discharge  
2. Incomplete/missing clinical and laboratory data, however this was not extensive 
and has been indicated in table 3.6. 
3. A significant proportion of patients went untested and therefore the HIV unknown 
group comprised a larger group than anticipated.  
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4. The HIV unknown group was older than the rest of the cohort 
5.  Nearly 20% of patients were excluded due to acute confusion at the time of the 
study, which may have possibly biased the proportion of neurological and 
neurocognitive disease in these patients. 
6. Information regarding the date of HIV diagnosis in those who were positive could 
not be accurately determined which did not allow for estimating the duration of 
known HIV disease 
7. This study was only conducted at a single site and may not be as representative as it 
may have been if conducted at all three sites, as initially planned 
 
4.7 Recommendations from the study 
This study demonstrated that older patients admitted to CHBAH had difficult socio-
economic circumstances and a significant burden of both infectious and non-
communicable disease. The prevalence of HIV infection (33.5%) was high in older 
hospitalised patients and more studies are required to investigate this finding. The results 
of this study may be useful in directing further research and assisting guidelines: 
1. Investigation of incidence and prevalence of HIV in the older South African 
population and in hospitalised patients. This will inform public health policy for 
management of chronic diseases, HIV, and the poor socio-economic factors that 
make older people vulnerable. 
2. Investigation of chronic disease profile in the older patients and an institution of 
policies and guidelines regarding management thereof.  
3. Recommendations for HIV screening and prevention programmes in the elderly. 
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4.  Specific Guidelines for ART initiation and management that take into account 
chronic illness and burdens of polypharmacy. 
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4.8 CONCLUSION 
HIV-positive patients admitted to CHBAH are younger and have poorer socioeconomic 
backgrounds than the HIV-negative patients from this community. They have less access 
to pension funds and higher rates of informal housing. Prevalence rates of HIV in 
hospitalised patients are high at 33.5%; this may be higher still as a third of hospitalised 
patients were not tested. The incidence of new infections diagnosed in this population was 
10% implying that HIV in the elderly will continue to present challenges for health care 
providers. There is a greater requirement for voluntary testing and counselling in this 
population group. The rates of infectious illnesses were significantly higher in older HIV-
positive patients compared to those who were HIV-negative. Acute clinical infectious 
disease of the respiratory and GIT were most prevalent in HIV-positive patients, while 
cardiac and haematological NCD disease predominated in the HIV-negative group. 
Hypertension and diabetes were the most prevalent chronic comorbid disease in this group, 
particularly those who were HIV-negative. CD4 counts were severely decreased in those 
patients who presented with predominantly infectious disease and opportunistic infectious 
illnesses continue to plague HIV-positive patients despite ART initiation. Both CD and 
NCD play an important role in hospitalisation of older adults. More research concerning 
HIV, the elderly and chronic CD and NCD is needed in order to advise future guidelines.
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APPENDIX C  
Data collection sheet 
 
 
 
Study no. 
   
 
Known HIV +ve  prior to 
admission  
                             
 
Y  ⃝ 
ART 
Y   ⃝ →→→ 
N   ⃝ 
Duration of 
ART (months) 
 
CD 4: 
HIVVL: 
(most recent) 
 
 
Age (years) 
   
 
HIV +ve  on admission 
                                       
 
Y  ⃝                                      
CD4 : 
HIVVL: 
(At time of diagnosis) 
 
 
Sex 
 
 
M ⃝           F  ⃝ 
 
 
 
HIV -ve 
 
Y  ⃝ 
HIV Status unknown 
Y  ⃝ 
Presenting Symptoms  
 
 
 
 
No. of dependants 
at home? 
 
1   ⃝          5  ⃝  
2   ⃝          6  ⃝ 
3   ⃝          7  ⃝  
4   ⃝          8  ⃝ 
I 
L 
L 
N 
E 
SS 
 
Final Dx (consultant opinion) 
 
 
 
 
Communicable  
 
Non-communicable 
 
 
 
 
Ethnicity 
Black              ⃝ 
White             ⃝ 
Indian             ⃝ 
Coloured        ⃝ 
 
C 
H 
R 
O 
N 
IC 
ILL 
NESS 
 
 
 
 
 
 
 
  
 
 
Area of permanent 
residence? 
House                        ⃝  
Shack                         ⃝ 
Flat                             ⃝ 
Non fixed dwelling  ⃝ 
 
 
Employed 
 
 
Y  ⃝          N  ⃝ →→ 
  
 
Source of income 
Social grant  ⃝ 
Pension         ⃝ 
Other             ⃝ Specify: 
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APPENDIX D 
WITS ACADEMIC TEACHING HOSPITALS 
Chris Hani Baragwanath  
Consent Form: Use of Clinical Information       
This document must be explained to the patient/family member/guardian by a member of the clinic staff 
and a copy of the signed document is to be given to the patient/family member/guardian. 
Dear Patient, 
You are currently being treated in the medical ward of the hospital for treatment of problems that you are 
currently experiencing. As a hospital in the University of the Witwatersrand academic complex, the hospital 
not only renders treatment, but is also actively involved in conducting research aimed at improving the 
quality of care we deliver. From time to time such research involves the use of patient records from which 
information is extracted.  
The use of such information is subject to: 
1. Approval from the Committee for Research on Human Subjects (University of the Witwatersrand) 
2. Anonymity, i.e. the identity of the patient from whose file the information is extracted is never 
revealed to anyone but the researcher, unless specific consent is obtained to do so. 
We are currently involved in a research project looking at the clinical presentation of patients over the age 
of 50 years. We would like to obtain your consent to use information from your file for the purpose of 
research, subject to the conditions mentioned above. If you choose not to give consent, this will not 
compromise your treatment in any way. If at any time you choose to withdraw your consent, you are free 
to do so and you will not be prejudiced in any manner whatsoever. (Please sign either section A or section 
B). Should you have any questions at any stage regarding this consent, or your rights as a research 
participant, please contact Anisa Keshav from the Human research Ethics Committee at 011 -717 1234 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Section A. 
I, ________________________________________________ hereby give consent for my records to be 
used as per the above-mentioned condition for the purposes of research: 
Patient:_____________________________________             Date:_______________________ 
Witness:_____________________________________             Date:_______________________ 
______________________________________________OR_______________________________________ 
Section B. 
I, ________________________________________________ do not give consent for my records to be used 
for research purposes: 
Patient:_____________________________________             Date:_______________________ 
Witness:_____________________________________             Date:_______________________ 
